MedTrace Logo

Maintaining Nonsmoking: Older Smokers - 1

NCT00086385 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 403

Last updated 2015-03-23

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to examine pharmacological and psychological interventions for smokers over 50.

Conditions

  • Tobacco Use Disorder

Interventions

DRUG

Nicotine polacrilex, Bupropion

Subjects receive 12 weeks of bupropion treatment and 10 weeks of nicotine replacement.

Sponsors & Collaborators

Principal Investigators

  • Sharon M Hall, Ph.D. · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-09-30
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00086385 on ClinicalTrials.gov